(Q43922213)

English

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

scientific article published on 25 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

E Clappier

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M F Auclerc

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Rapion

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M Bakkus

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Caye

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Khemiri

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Giroux

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

L Hernandez

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

E Kabongo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

T Leblanc

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

K Yakouben

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Plat

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

V Costa

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Ferster

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Girard

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

O Fenneteau

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J M Cayuela

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

F Sigaux

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

N Dastugue

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Suciu

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Y Benoit

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Y Bertrand

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Soulier

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

25 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

70-77

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

https://scigraph.springernature.com/pub.10.1038/leu.2013.277

0 references

Genetic aberrations in paediatric acute leukaemias and implications for management of patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

B-lineage transcription factors and cooperating gene lesions required for leukemia development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

ERG is a megakaryocytic oncogene.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Genomic profiling of high-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.277

21 January 2018

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2013.277

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Dimensions Publication ID

0 references

release_wre7pcxa6jcq7avcghleihffqm

1 reference

https://api.fatcat.wiki/v0/release/wre7pcxa6jcq7avcghleihffqm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24064621%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43922213&oldid=2104410144"